CM
BDSI

Castleark Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Castleark Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-168,125
Closed -$2.87M – 448
2013
Q3 		$2.87M Buy
+168,125
New +$808K 0.08% 206

Other funds holding BDSI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Castleark Management's BDSI Position: Q4 2013 in Review

Castleark Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2013, closing a stake of 168,125 shares — an estimated $2.87M sold.

Castleark Management first reported a position in BDSI in Q3 2013 and held it in 1 quarter. The position peaked at $2.87M in Q3 2013. 75 funds tracked by Wall St. Rank hold BDSI as of Q4 2013.

  • Castleark Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2013 after selling out during the quarter.
  • Castleark Management sold 168,125 BioDelivery Sciences International, Inc. shares in Q4 2013, an estimated $2.87M.
  • Castleark Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 1 quarter.
  • Castleark Management's BioDelivery Sciences International, Inc. position peaked at $2.87M in Q3 2013.
  • 75 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2013.

Based on Castleark Management's 13F filing for Q4 2013, filed 20 Feb 2014.